Careers  |  Sign In  |  Register  |   Twitter

Idraparinux and Excess Bleeding

A clinical trial halted

This video discusses how significant excess bleeding halted a trial of idraparinux for stroke prevention in patients with atrial fibrillation.

References and Resources
The Amadeus Investigators. Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial. The Lancet 2008; 371:315-321.

Sponsored by the Doctor’s Channel